Anavex Life Sciences Corp (AVXL)

[rx7171]

A EU conservative 4 million patients at a conservative $5,000 per year is still a gross of $20 billion.

Let Anavex go alone without giving away a big chunk to a BP.

What are cost of product, distribution and marketing?
Marketing will be word of mouth almost immediately among the AD community and doctors.
Distribution of pills as simple as aspirin.
A while back someone quoted Missling as saying cost of manufacturing 60 cents a pill.
Missling says the company already has ample supply on hand ready to go.

So let’s say 2 billion overhead at most in total for a net of $18 billion a year.

With 80 million shares that is ~$220 per share.
With a conservative P/E of 15/1
that gives us a share price of ~$3,300

Cut patient count or cost per patient in half still gives us $1,650 a share. 🤷‍♂️